⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 1994Journal of Immunotherapy

PHASE II TRIAL OF 131I-CC49 Mab PLUS ALPHA INTERFERON (rIFNα) IN BREAST CANCER

James L. Murray Daniel J. Macey Edward Grant Michael G. Rosenblum Leela P. Kasi Zhang Hz R. L. Katz Paula Trahan Rieger Donna LeBherz V. P. Bhadkamkar Michael S. South Jeffrey Schlom Donald A. Podoloff

View at Publisher

Ask AI

Bookmark

Share

Abstract

s: Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer: Session IX: Clinical Radioimmunotherapy, II: PDF Only

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Murray et al. (1994) studied this question.

synapsesocial.com/papers/6aace1e3cae1af65714f8e9e https://doi.org/10.1097/00002371-199408000-00066

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Area Deprivation Index and Survival Outcomes for Patients With Metastatic Solid Tumors Treated With Immune Checkpoint Inhibitors in the United StatesJournal of Immunotherapy · 2026
2Immune Checkpoint Inhibitors After Chemoradiation in Unresectable Non–Small Cell Lung Cancer: Survival Outcomes From a Tertiary Care Center in LebanonJournal of Immunotherapy · 2026
3Immunostaining of p53 Is Associated With Efficacy of Anti-PD-1 Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaJournal of Immunotherapy · 2026
4Association Between Neoadjuvant Immunochemotherapy Efficacy and Pathologic Characteristics in dMMR Gastric/Gastroesophageal Junction AdenocarcinomaJournal of Immunotherapy · 2026
5Clinical Features, Treatment, and Outcomes of Sintilimab-induced Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisJournal of Immunotherapy · 2026

Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated KillingJournal of Immunotherapy · 2026
Auranofin Sensitizes Oral Squamous Cell Carcinoma to PD-1 Blockade Through DUSP1-Associated Macrophage ReprogrammingJournal of Immunotherapy · 2026
Armoring CAR-T Cells Against Exhaustion: Engineering Strategies for GlioblastomaJournal of Immunotherapy · 2026
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three PatientsJournal of Immunotherapy · 2026
IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR PathwayJournal of Immunotherapy · 2026

More from Journal of Immunotherapy